✦ LIBER ✦

Efficacy and safety of pravastatin in the long-term treatment of elderly patients with hypercholesterolemia

✍ Scribed by John T. Santinga; Howard S. Rosman; Melvyn Rubenfire; James J. Maciejko; Lester Kobylak; Mark E. McGovern; Bruce D. Behounek

Book ID: 115684646
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 862 KB
Volume: 96
Category: Article
ISSN: 1555-7162
DOI: 10.1016/0002-9343(94)90090-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of atorvastatin and

Efficacy and safety of atorvastatin and pravastatin in patients with hypercholesterolemia

✍ G Assmann; D Hüwel; K.-M Schussman; J.G Smilde; M Kösling; A.J.A.M Withagen; J W 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Long-term safety and efficacy of high-do

Long-term safety and efficacy of high-dose atorvastatin treatment in patients with familial hypercholesterolemia

✍ Sanne van Wissen; Tineke J. Smilde; Mieke D. Trip; Anton F.H. Stalenhoef; John J 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Long-Term Efficacy and Safety of Rosuvas

Long-Term Efficacy and Safety of Rosuvastatin 40 mg in Patients With Severe Hypercholesterolemia

✍ Evan A. Stein; John Amerena; Christie M. Ballantyne; Edmund Brice; Michel Farnie 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 341 KB

Long-term efficacy and tolerability of p

Long-term efficacy and tolerability of pravastatin in hypercholesterolemia in patients with non-insulin-dependent diabetes mellitus

✍ Tsutomu Kazumi; Gen Yoshino; Yoshihiko Ishida; Ippei Iwatani; Soichiro Morita; M 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 662 KB

Long-Term Efficacy and Safety of Cerivas

Long-Term Efficacy and Safety of Cerivastatin 0.8 mg in Patients with Primary Hypercholesterolemia

✍ Jonathan Isaacsohn; William Insull; Evan Stein; Peter Kwiterovich; Ma Patrick; R 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 842 KB

Long-term safety and efficacy of long-ac

Long-term safety and efficacy of long-acting risperidone in elderly psychotic patients

✍ Werner Kissling; Per Glue; Rossella Medori; Steve Simpson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

## Abstract This subgroup analysis of the 6‐month, open‐label Switch to Risperidone Microspheres (StoRMi) trial evaluated long‐term safety and efficacy of a direct conversion to risperidone long‐acting injectable (RLAI) in 52 elderly patients (≥65 years) with psychosis stabilized on oral or depot a